cervical adenosquamous carcinoma
Showing 1 - 25 of 29
Cervical Adenocarcinoma, Cervical Adenosquamous Carcinoma, Recurrent Cervical Carcinoma Trial in United States (Laboratory
Active, not recruiting
- Cervical Adenocarcinoma
- +5 more
- Laboratory Biomarker Analysis
- Nivolumab
-
Birmingham, Alabama
- +336 more
Jan 28, 2023
Human Papilloma Virus Circulating Tumor DNA in Cervical Cancer
Recruiting
- Cervical Adenosquamous Carcinoma
- +26 more
- Biospecimen Collection
-
Rochester, MinnesotaMayo Clinic in Rochester
Jan 4, 2023
Cervical Adenocarcinoma, Cervical Adenosarcoma, Cervical Adenosquamous Carcinoma Trial in United States (biological, other,
Recruiting
- Cervical Adenocarcinoma
- +47 more
- Bevacizumab
- +3 more
-
Phoenix, Arizona
- +3 more
Dec 5, 2022
MRI and PET Imaging in Predicting Treatment Response in Stage
Active, not recruiting
- Cervical Adenocarcinoma
- +12 more
- Computed Tomography
- +5 more
-
Miami, Florida
- +5 more
Oct 4, 2022
Advanced Vaginal Adenocarcinoma, Advanced Vaginal Adenosquamous Carcinoma, Advanced Vaginal Squamous Cell Carcinoma Trial in
Recruiting
- Advanced Vaginal Adenocarcinoma
- +20 more
- Brachytherapy
- +6 more
-
Birmingham, Alabama
- +383 more
Aug 18, 2022
Cervical Adenocarcinoma, Cervical Adenosquamous Carcinoma, Cervical Squamous Cell Carcinoma, Not Otherwise Specified Trial in
Recruiting
- Cervical Adenocarcinoma
- +11 more
- Media Intervention
- +4 more
-
Houston, TexasM D Anderson Cancer Center
Jun 15, 2022
Cervical Adenocarcinoma, Cervical Adenosquamous Carcinoma, Cervical Squamous Cell Carcinoma, Not Otherwise Specified Trial in
Withdrawn
- Cervical Adenocarcinoma
- +6 more
- Carboplatin
- +4 more
-
Cape Town, South Africa
- +2 more
Jun 14, 2022
Hybrid PET/MR in the Therapy of Cervical Cancer
Completed
- Cervix Carcinoma
- +2 more
- FDG PET/MR
-
Chapel Hill, North CarolinaUniversity of North Carolina-Chapel Hill
Dec 2, 2021
Cervical Adenocarcinoma, Cervical Adenosquamous Carcinoma, Cervical Squamous Cell Carcinoma, Not Otherwise Specified Trial in
Completed
- Cervical Adenocarcinoma
- +6 more
- Atezolizumab
- +2 more
-
Los Angeles, California
- +21 more
Apr 20, 2021
Cervical Adenocarcinoma, Cervical Adenosquamous Carcinoma, Cervical Squamous Cell Carcinoma, Not Otherwise Specified Trial in
Completed
- Cervical Adenocarcinoma
- +3 more
- Attenuated Live Listeria Encoding HPV 16 E7 Vaccine ADXS11-001
- Laboratory Biomarker Analysis
-
Birmingham, Alabama
- +23 more
Aug 21, 2020
Cervical Adenocarcinoma, Cervical Adenosquamous Carcinoma, Cervical Squamous Cell Carcinoma, Not Otherwise Specified Trial in
Completed
- Cervical Adenocarcinoma
- +8 more
- Cisplatin
- +4 more
-
Los Angeles, California
- +15 more
Sep 1, 2020
Cervical Carcinoma, Cervical Adenocarcinoma, Cervical Adenosquamous Carcinoma Trial run by the NCI (Ixempra (Ixabepilone
Terminated
- Cervical Carcinoma
- +3 more
- Ixempra (Ixabepilone (BMS-247550) )
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Nov 13, 2019
Cervical Adenocarcinoma, Cervical Adenosquamous Carcinoma, Cervical Small Cell Carcinoma Trial in United States (biological,
Completed
- Cervical Adenocarcinoma
- +7 more
- Filgrastim
- +4 more
-
Orange, California
- +77 more
Aug 6, 2019
Cervical Adenocarcinoma, Cervical Adenosquamous Carcinoma, Cervical Squamous Cell Carcinoma, Not Otherwise Specified Trial in
Completed
- Cervical Adenocarcinoma
- +4 more
- Cisplatin
- +3 more
-
Los Angeles, California
- +24 more
Jul 17, 2019
Cervical Adenocarcinoma, Cervical Adenosquamous Carcinoma, Cervical Squamous Cell Carcinoma, Not Otherwise Specified Trial in
Completed
- Cervical Adenocarcinoma
- +4 more
- Brivanib Alaninate
- Laboratory Biomarker Analysis
-
Phoenix, Arizona
- +42 more
Mar 8, 2019
Cervical Adenocarcinoma, Cervical Adenosquamous Carcinoma, Cervical Squamous Cell Carcinoma, Not Otherwise Specified Trial in
Unknown status
- Cervical Adenocarcinoma
- +8 more
- Carboplatin
- +4 more
-
Orange, California
- +13 more
Mar 8, 2019
Cervical Adenocarcinoma, Cervical Adenosquamous Carcinoma, Cervical Small Cell Carcinoma Trial in United States (Paclitaxel
Completed
- Cervical Adenocarcinoma
- +4 more
- Paclitaxel Albumin-Stabilized Nanoparticle Formulation
- Laboratory Biomarker Analysis
-
Aurora, Colorado
- +25 more
Dec 17, 2018
Cervical Adenocarcinoma, Cervical Adenosquamous Carcinoma, Cervical Squamous Cell Carcinoma Trial in Philadelphia (Cisplatin,
Completed
- Cervical Adenocarcinoma
- +4 more
- Cisplatin
- +5 more
-
Philadelphia, PennsylvaniaGynecologic Oncology Group
Sep 18, 2018
Cervical Adenocarcinoma, Cervical Adenosquamous Carcinoma, Cervical Squamous Cell Carcinoma, Not Otherwise Specified Trial in
Completed
- Cervical Adenocarcinoma
- +6 more
- Bevacizumab
- +3 more
-
Burbank, California
- +105 more
Feb 21, 2018
Cervical Adenocarcinoma, Cervical Adenosquamous Carcinoma, Cervical Squamous Cell Carcinoma Trial in Philadelphia (drug,
Terminated
- Cervical Adenocarcinoma
- +3 more
- Isosulfan Blue
- +7 more
-
Philadelphia, PennsylvaniaGynecologic Oncology Group
Oct 3, 2017
Glycoprotein and Glycan in Tissue and Blood Samples of Stage
Completed
- Cervical Adenocarcinoma
- +8 more
- Laboratory Biomarker Analysis
- Lymphadenectomy
-
Orange, California
- +17 more
Aug 23, 2017
Cervical Adenocarcinoma, Cervical Adenosquamous Carcinoma, Recurrent Cervical Carcinoma Trial in Phoenix (Capecitabine,
Completed
- Cervical Adenocarcinoma
- +2 more
- Capecitabine
- Laboratory Biomarker Analysis
-
Phoenix, ArizonaGynecologic Oncology Group of Arizona
Aug 23, 2017
Anemia, Cervical Adenocarcinoma, Cervical Adenosquamous Carcinoma Trial in Phoenix (radiation, drug, biological)
Completed
- Anemia
- +8 more
- External Beam Radiation Therapy
- +3 more
-
Phoenix, ArizonaGynecologic Oncology Group of Arizona
Aug 8, 2017
Collecting Tumor Samples From Patients With Gynecological Tumors
Completed
- Borderline Ovarian Clear Cell Tumor
- +85 more
- Laboratory Biomarker Analysis
-
Fayetteville, Arkansas
- +186 more
Oct 26, 2016
Cervical Adenocarcinoma, Cervical Adenosquamous Carcinoma, Cervical Squamous Cell Carcinoma Trial in Bronx (Paclitaxel,
Completed
- Cervical Adenocarcinoma
- +5 more
-
Bronx, New YorkMontefiore Medical Center - Moses Campus
Oct 16, 2015